Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

News

PEDro scale is valid and reliable in pharmaceutical trials

The validity (convergent and construct) and inter-rater reliability of the PEDro scale has been evaluated for pharmaceutical trials. 53 randomised placebo controlled trials evaluating any pain medication for chronic spinal pain or osteoarthritis were assessed by two raters. Convergent validity was evaluated by correlating the total PEDro score with the summary score of the Cochrane Back and Neck Group risk of bias tool. Construct validity was tested using a linear regression analysis to determine the degree to which the total PEDro score was associated with treatment effect sizes, journal impact factor and the summary score for the Cochrane Back and Neck Group risk of bias tool. The correlation between the total PEDro score and summary score for the Cochrane Back and Neck Group risk of bias tool was 0.83 (95% CI 0.76 to 0.88), indicating strong convergence. The total PEDro score was inversely associated with effect sizes, significantly associated with the summary score for the Cochrane Back and Neck Group risk of bias tool, and not associated with the journal impact factor. The inter-rater reliability for each item of the PEDro scale and Cochrane Back and Neck Group risk of bias tool was at least substantial for most items (Prevalence and Bias Adjusted Kappa > 0.60). The Intraclass Correlation Coefficient was 0.80 (95% CI 0.68 to 0.88) for the total PEDro score and 0.81 (95% CI 0.69 to 0.88) for the Cochrane Back and Neck Group risk of bias tool summary score. There was evidence for the convergent and construct validity for the PEDro scale. Both the PEDro scale and Cochrane Back and Neck Group risk of bias tool have acceptably high inter-rater reliability.

Yamato et al. The PEDro scale had acceptably high convergent validity, construct validity and inter-rater reliability in evaluating methodological quality of pharmaceutical trials. J Clin Epidemiol 2017;86:176-81

Sign up to the PEDro Newsletter to receive the latest news